Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs)
$124.08
pos +1.43
+1.17%
Today's Range: 122.25 - 124.18 | AMGN Avg Daily Volume: 2,960,200
Last Update: 07/29/14 - 1:11 PM EDT
Volume: 1,692,146
YTD Performance: 7.51%
Open: $122.52
Previous Close: $122.65
52 Week Range: $103.31 - $128.96
Oustanding Shares: 757,021,648
Market Cap: 92,992,539,240
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 8 8 8
Moderate Buy 1 1 1 1
Hold 9 10 10 11
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.16 2.08 2.08 2.13
Latest Dividend: 0.61
Latest Dividend Yield: 1.99%
Dividend Ex-Date: 08/12/14
Price Earnings Ratio: 19.94
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
19.94 20.00 28.94
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.02% 11.91% 129.55%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.20 0.24 0.07
Net Income 16.90 0.10 0.03
EPS 20.30 0.40 0.12
Earnings for AMGN:
EBITDA 7.35B
Revenue 18.68B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.99 $2.09 $8.10 $8.78
Number of Analysts 3 3 3 3
High Estimate $2.03 $2.15 $8.18 $9.04
Low Estimate $1.93 $2.02 $7.99 $8.56
Prior Year $1.88 $1.93 $7.57 $8.10
Growth Rate (Year over Year) 5.67% 8.29% 6.96% 8.48%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
On a daily time frame, as long as it holds a key support level, it's a possible buy.
Hologic, Symantec and TE Connectivity could all benefit from the current M&A binge.
For now, just let the market do the heavy lifting for you.

Biotechs Flash the Green Light Real Money Pro($)

After a decline, the sector has built a base, and these names are breaking out.
Spice up your portfolio with some takeover bait.
Its pipeline appears strong enough to overcome patent-expiration issues.
If the stock doesn't breach support, here's where I'd buy in.
Their peak prices were out of line -- not the subsequent selloffs.
Bearish
Apr 23, 2014 | 8:15 AM EDT
Shares of AMGN now seen reaching $129, according to Nomura. Estimates also reduced, as the company lacks visibility with its latest gui...
Bearish
Apr 23, 2014 | 7:20 AM EDT
AMGN lowered its numbers, Jefferies said. Lower product sales impacted by historical patterns and inventory drawdown. $142 price target...

Columnist Conversations

This one has met a minor target already, the next target comes in at 119.91-120.03, then 121.53. Trail up sto...
Katz:
ETN reported their earnings earlier today and just finished their quarterly conference call. Earnings were in...
Dollar call buyer in Dollar Tree. With shares near morning lows of $54.03 a buyer paid $1 for more than 3500 A...
Corning is taking a major beating this morning. The stock began the session with a huge downside gap af...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.